Should you buy Koninklijke Philips N.V. NY Reg (PHG)?
Updated
Philips has delivered four consecutive earnings beats with an average surprise of 39.4% and free cash flow at 157% of net income, but trades below its 200-day moving average with declining revenues of -5% and a below-average quality score of 4.7.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Engine methodology range
Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.
What the engine is tracking
| Pillar | Expectation | Trend |
|---|---|---|
Philips has beaten earnings estimates in all 4 of the last 4 quarters with an exceptional average surprise of 39.4%, the largest magnitude beat streak in the data, suggesting analyst estimates are consistently too conservative. Catalyst breakdown | Earnings beat streak extends to 6 quarters with average surprise remaining above 25%, continuing to outperform consensus. | →Stable |
| CounterConsistently large positive surprises may indicate management is guiding low rather than that the business is structurally improving; eventually consensus adjusts and beats shrink. | ||
Revenue is declining at -5% annually, the quality score sits at 4.7, and the stock trades below its 200-day moving average — key concerns that offset the strong earnings beat pattern. Growth breakdown | Revenue returns to flat or positive growth and quality score rises above 5.5 within 12 months. | →Stable |
| CounterRevenue decline in medical devices often precedes a rebound as product cycles reset; the 157% free cash flow conversion relative to net income suggests the business generates real cash even during revenue headwinds. | ||
Free cash flow is 157% of net income with a Piotroski F-Score of 7 out of 9, indicating that Philips converts reported earnings into cash at a rate well above par, supporting balance sheet stability. Quality breakdown | Free cash flow conversion remains above 120% of net income for 4 consecutive quarters. | →Stable |
| CounterWithout a recognized competitive moat and with declining revenues, even strong cash conversion may not prevent further margin compression as the turnaround remains uncertain. | ||
Philips has beaten earnings estimates in all 4 of the last 4 quarters with an exceptional average surprise of 39.4%, the largest magnitude beat streak in the data, suggesting analyst estimates are consistently too conservative.
→Stable- Expectation
- Earnings beat streak extends to 6 quarters with average surprise remaining above 25%, continuing to outperform consensus.
CounterConsistently large positive surprises may indicate management is guiding low rather than that the business is structurally improving; eventually consensus adjusts and beats shrink.
Revenue is declining at -5% annually, the quality score sits at 4.7, and the stock trades below its 200-day moving average — key concerns that offset the strong earnings beat pattern.
→Stable- Expectation
- Revenue returns to flat or positive growth and quality score rises above 5.5 within 12 months.
CounterRevenue decline in medical devices often precedes a rebound as product cycles reset; the 157% free cash flow conversion relative to net income suggests the business generates real cash even during revenue headwinds.
Free cash flow is 157% of net income with a Piotroski F-Score of 7 out of 9, indicating that Philips converts reported earnings into cash at a rate well above par, supporting balance sheet stability.
→Stable- Expectation
- Free cash flow conversion remains above 120% of net income for 4 consecutive quarters.
CounterWithout a recognized competitive moat and with declining revenues, even strong cash conversion may not prevent further margin compression as the turnaround remains uncertain.
▸ Show 1 more pillar▾ Show fewer
At a forward P/E of 13.1x and PEG ratio of 0.87, Philips is reasonably valued with a 9.3% upside to the analyst target of $29.18 from a current price of $26.69.
→Stable- Expectation
- Price rises above $29.00 within 12 months as earnings beats support a valuation re-rating.
CounterA 9.3% upside is a thin margin of safety, and if revenues continue declining the analyst target may be revised downward, eliminating the current cushion.
→ Full pillar scorecard with all 4 pillars + per-dimension breakdown
When this thesis breaks
Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Philips has beaten earnings estimates in all 4 of the last 4 quarters with an exceptional average surprise of 39.4%, the largest magnitude beat streak in the data, suggesting analyst estimates are consistently too conservative.
Trip ifEarnings miss consensus by more than 10% in any 1 of the next 2 quarterly reports, breaking the 39% average beat pattern.
- P2Revenue is declining at -5% annually, the quality score sits at 4.7, and the stock trades below its 200-day moving average — key concerns that offset the strong earnings beat pattern.
Trip ifRevenue declines more than 8% year-over-year for 2 consecutive quarters, indicating accelerating contraction beyond the current -5% rate.
- P3Free cash flow is 157% of net income with a Piotroski F-Score of 7 out of 9, indicating that Philips converts reported earnings into cash at a rate well above par, supporting balance sheet stability.
Trip ifFree cash flow conversion falls below 80% of net income for 2 consecutive quarters, signaling cash generation deterioration.
- P4At a forward P/E of 13.1x and PEG ratio of 0.87, Philips is reasonably valued with a 9.3% upside to the analyst target of $29.18 from a current price of $26.69.
Trip ifAnalyst consensus price target falls below $24.00, eliminating the current 9.3% upside cushion and pushing implied return below 0%.
How the engine reached this verdict
TrendMatrix's engine output for Koninklijke Philips N.V. NY Reg (PHG) is HOLD_IF_HOLDING with medium conviction, score 5.5/10 at $26.73. None of the engine's positive-conviction paths (C-quality, D-momentum) cleared their gates — the F-path HOLD reflects balanced signals rather than directional conviction.
Koninklijke Philips N.V. NY Reg (PHG) sits at overall score 5.5/10 with no actively-failing gates (strongest-cleared: MOMENTUM:6.3>=5.5). HOLD flips toward BUY_WAIT when a positive-conviction path (C-quality or D-momentum) triggers; toward SELL when any of the currently-passing gates drop below threshold or three+ dimensions fall below 4 simultaneously.
The engine is not issuing fresh-money entry targets at the current verdict. The technical entry zone is around — with a technical stop near $25.53 for existing positions. Asymmetric R:R is 2.04, below the threshold (≥2.0) at which the engine would actively flag fresh capital. The engine's sizing output: 0.5% of portfolio at this asymmetry level (none-conviction tier).
On the bull side: Strong earnings beat streak (4/4). On the bear side: Thin upside margin: 9.2%; Below 200-day MA.
For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates PHG — 10-dimension breakdown →
Bull case
- ▸Strong earnings beat streak (4/4)
Bear case
- ▸Thin upside margin: 9.2%
- ▸Below 200-day MA